2005
DOI: 10.1016/j.hfc.2004.12.003
|View full text |Cite
|
Sign up to set email alerts
|

Role of Aldosterone Blockade in Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 67 publications
0
1
0
Order By: Relevance
“…Within the last 10 years, blocking its effects with MR antagonists has been shown to have beneficial effects in congestive heart failure, especially after myocardial infarction, and proteinuric nephropathies. 28,29 Although our results need to be replicated in larger cohorts well phenotyped for BP and the renin-angiotensin-aldosterone axis, our data suggest that functional variants of the MR may be associated not only with different cellular responses to aldosterone but also, indirectly, with increased aldosterone levels that may activate both genomic and nongenomic pathways in nonepithelial target tissues to promote deleterious cardiovascular effects.…”
Section: Van Leeuwen Et Al Mr Polymorphism and Blood Pressure Regulationmentioning
confidence: 73%
“…Within the last 10 years, blocking its effects with MR antagonists has been shown to have beneficial effects in congestive heart failure, especially after myocardial infarction, and proteinuric nephropathies. 28,29 Although our results need to be replicated in larger cohorts well phenotyped for BP and the renin-angiotensin-aldosterone axis, our data suggest that functional variants of the MR may be associated not only with different cellular responses to aldosterone but also, indirectly, with increased aldosterone levels that may activate both genomic and nongenomic pathways in nonepithelial target tissues to promote deleterious cardiovascular effects.…”
Section: Van Leeuwen Et Al Mr Polymorphism and Blood Pressure Regulationmentioning
confidence: 73%